Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $71.63 | $37.77 | 89.63% | 47.44x | 34.42x | 7.93x | 9.40x | 0.71x | $194.62M | 2.55% | $833.74M | 7.82 | $7.75B | 69.87 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.00 | $8.61 | 213.42% | 122.73x | 61.96x | 6.95x | 13.99x | 1.08x | $59.71M | 1.69% | $243.97M | 1.86 | $3.50B | 74.70 | ||
| RPRX | ROYALTY PHARMA PLC | $67.57 | $35.36 | 91.08% | 44.16x | 12.45x | 11.52x | 3.96x | 0.73x | $2.89B | 9.60% | $9.80B | 21.96 | $46.83B | 44.88 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $299.00 | $75.34 | 296.87% | 112.83x | 31.12x | 23.51x | 6.22x | 1.44x | $90.43M | 1.52% | $961.76M | 48.18 | $7.08B | 71.87 | ||
| HALO | HALOZYME THERAPEUTICS INC | $122.96 | $72.62 | 69.33% | 34.54x | 13.64x | 8.67x | 97.22x | 0.67x | $806.22M | 5.59% | $143.54M | 1.22 | $15.94B | 22.18 | ||
| KRYS | KRYSTAL BIOTECH INC | $300.25 | $78.37 | 283.13% | 39.20x | 40.03x | 18.91x | 6.20x | 2.16x | $310.08M | 3.49% | $1.44B | 48.48 | $8.44B | 31.80 | ||
| VCEL | VERICEL CORP | $51.78 | $8.21 | 530.97% | 107.88x | 91.87x | 8.63x | 7.17x | 2.65x | $61.66M | 2.33% | $370.04M | 7.25 | $2.62B | 59.45 | ||
| TGTX | TG THERAPEUTICS INC | $57.98 | $22.99 | 152.20% | 18.82x | 56.56x | 10.28x | 14.69x | 2.10x | $17.39M | 0.21% | $604.08M | 4.26 | $9.14B | 65.68 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $227.32 | $131.05 | 73.46% | 62.45x | 15.03x | 3.12x | 3.48x | 0.61x | $1.65B | 11.24% | $4.19B | 64.79 | $18.19B | 15.87 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $88.34 | $14.81 | 496.59% | 61.78x | 68.05x | 7.30x | 9.77x | 3.34x | $197.20M | 2.85% | $710.19M | 9.08 | $6.87B | 45.17 | ||
| ADMA | ADMA BIOLOGICS INC | $13.21 | $7.00 | 88.69% | 16.72x | 16.60x | 5.69x | 6.68x | 1.23x | $132.91M | 4.50% | $438.51M | 1.96 | $3.00B | 11.89 | ||
| EXEL | EXELIXIS INC | $68.71 | $32.32 | 112.59% | 19.92x | 19.93x | 6.79x | 9.14x | 1.31x | $1.16B | 6.85% | $1.83B | 7.43 | $16.62B | 14.88 | ||
| INCY | INCYTE CORP | $118.01 | $54.48 | 116.60% | 56.46x | 35.17x | 3.99x | 4.26x | 0.80x | $684.87M | 2.86% | $5.64B | 27.76 | $20.81B | 23.20 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $542.50 | $155.63 | 248.59% | 34.62x | 28.31x | 10.62x | 6.58x | 2.02x | $3.20B | 2.33% | $20.91B | 82.48 | $139.04B | 27.61 | ||
| TECH | BIO-TECHNE CORP | $72.66 | $16.73 | 334.39% | 62.10x | 34.97x | 9.33x | 5.40x | 1.97x | $263.22M | 2.32% | $2.11B | 13.52 | $11.42B | 32.84 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.53 | $6.48 | 62.39% | 8.29x | 9.68x | 4.23x | 2.62x | 7.02x | $87.07M | 13.92% | $238.92M | 4.02 | $505.66M | 5.26 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $902.90 | $466.24 | 93.66% | 19.21x | 14.03x | 5.43x | 2.79x | 1.12x | $3.83B | 4.17% | $33.50B | 329.39 | $92.45B | 14.80 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $32.47 | $31.93 | 1.68% | 10.51x | 7.83x | 1.92x | 1.78x | 0.57x | $322.93M | 17.03% | $1.07B | 18.36 | $1.41B | 5.19 | ||
| UTHR | UNITED THERAPEUTICS CORP | $565.72 | $214.73 | 163.46% | 19.80x | 20.74x | 7.58x | 3.84x | 2.17x | $867.20M | 3.59% | $6.28B | 146.98 | $22.90B | 14.18 | ||
| VCYT | VERACYTE INC | $24.00 | $12.23 | 96.27% | 16.67x | 12.37x | 3.42x | 1.39x | 1.35x | $165.99M | 8.65% | $1.39B | 17.36 | $1.67B | 11.94 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.